Parallax Volatility Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
400,000
+150,000
+60% +$842K 0.01% 749
2025
Q4
$1.75M Hold
250,000
﹤0.01% 986
2025
Q3
$1.93M Hold
250,000
﹤0.01% 936
2025
Q2
$2.18M Hold
250,000
﹤0.01% 853
2025
Q1
$1.99M Buy
250,000
+209,700
+520% +$2.12M 0.01% 870
2024
Q4
$366K Hold
40,300
﹤0.01% 1562
2024
Q3
$370K Hold
40,300
﹤0.01% 1580
2024
Q2
$394K Hold
40,300
﹤0.01% 1481
2024
Q1
$609K Sell
40,300
-84,300
-68% -$1.53M ﹤0.01% 1350
2023
Q4
$2.69M Sell
124,600
-1,600
-1% -$29.5K 0.01% 1072
2023
Q3
$2.35M Buy
126,200
+39,600
+46% +$924K 0.01% 1036
2023
Q2
$2.19M Sell
86,600
-119,000
-58% -$3M ﹤0.01% 1104
2023
Q1
$5.33M Sell
205,600
-697,000
-77% -$18.7M 0.01% 834
2022
Q4
$21.3M Buy
902,600
+300,500
+50% +$8.1M 0.03% 511
2022
Q3
$15.3M Sell
602,100
-366,200
-38% -$12.8M 0.02% 614
2022
Q2
$32.2M Sell
968,300
-454,500
-32% -$19.3M 0.03% 369
2022
Q1
$103M Buy
1,422,800
+1,089,600
+327% +$78.5M 0.05% 133
2021
Q4
$30.6M Sell
333,200
-203,900
-38% -$24.4M 0.04% 328
2021
Q3
$68.1M Buy
537,100
+278,000
+107% +$40.5M 0.07% 199
2021
Q2
$43.1M Buy
259,100
+192,200
+287% +$31.1M 0.06% 213
2021
Q1
$12.2M Sell
66,900
-219,400
-77% -$50.9M 0.03% 353
2020
Q4
$57.2M Buy
286,300
+225,100
+368% +$45.8M 0.06% 271
2020
Q3
$13.4M Sell
61,200
-108,400
-64% -$23M 0.01% 869
2020
Q2
$32.4M Buy
169,600
+116,000
+216% +$20.3M 0.04% 372
2020
Q1
$8.32M Buy
53,600
+21,600
+68% +$2.51M 0.01% 681
2019
Q4
$2.68M Buy
+32,000
New +$2.44M ﹤0.01% 1148
2018
Q1
Sell
-62,300
Closed -$2.17M 4125
2017
Q4
$2.17M Buy
+62,300
New +$2.07M ﹤0.01% 891

Other funds holding TDOC

Parallax Volatility Advisers's TDOC Position: Q4 2025 in Review

Parallax Volatility Advisers sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 16,322 shares — an estimated $128K sold.

Parallax Volatility Advisers first reported a position in TDOC in Q4 2017 and held it in 18 quarters. The position peaked at $88.1M in Q4 2021. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Parallax Volatility Advisers reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 16,322 Teladoc Health shares in Q4 2025, an estimated $128K.
  • Parallax Volatility Advisers first reported a position in Teladoc Health in Q4 2017 and held it in 18 quarters.
  • Parallax Volatility Advisers's Teladoc Health position peaked at $88.1M in Q4 2021.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.